Compare State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF (FLRN) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF vs Teladoc Health Inc — how do they compare? State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF trades at $30.76 (market cap $3.06B), while Teladoc Health Inc trades at $5.54 (market cap $1.01B). The key difference: State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF is far larger — about 3× Teladoc Health Inc's market cap, and State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF is trading nearer its 52-week high, Teladoc Health Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF for 15 Days and Teladoc Health Inc for 39 Days on average.
| FLRN | TDOC | |
|---|---|---|
Market Cap | $3.06B | $1.01B |
Volume | 465,116 | 3,622,440 |
Sector | Fixed Income | Health |
52-Week High | $30.86 | $9.72 |
52-Week Low | $30.65 | $4.47 |
Typical Hold Time | 15 Days | 39 Days |
Enterprise Value | — | $1.27B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLRN (SPDR Bloomberg Investment Grade Floating Rate ETF) trades at $30.75 with minimal daily movement (+0.03%). Technical indicators show a bearish trend with strong selling pressure in moving averages, while oscillators remain neutral. The ETF maintains consistent $0.11 quarterly dividend payments through 2026, providing income stability amid current market volatility.
FLRN offers protection against rising interest rates with near-zero duration exposure, though significant financial sector concentration presents risk. Current market sentiment reflects cautious optimism as institutional investors add positions while technical indicators suggest near-term pressure. The floating rate structure positions FLRN favorably in inflationary environments.
Teladoc Health (TDOC) trades at $5.54, down 3.99% in the latest session, reflecting ongoing investor concerns despite recent earnings beats. The stock shows bearish technical signals with oversold conditions while fundamentals reveal a mixed picture - strong gross margins of 68.97% but persistent net losses. Recent management changes and legal investigations add uncertainty, though the company maintains solid cash flow from operations of $294.36 million.
TDOC presents a high-risk opportunity with significant upside potential given the $8.83 consensus price target, representing 59% upside. However, continued net losses, negative cash flow trends, and competitive pressures in telehealth create substantial execution risk. The stock's current valuation at 0.4x sales appears attractive if the company can achieve profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF
FLRN invests in U.S. dollar-denominated investment-grade floating rate notes with maturities under five years. It provides exposure to corporate and supranational debt whose interest payments adjust with market rates, helping to mitigate interest rate risk.
Read more on FLRN →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
